These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 11286307

  • 21. AMP-activated protein kinase control of energy metabolism in the ischemic heart.
    Lopaschuk GD.
    Int J Obes (Lond); 2008 Sep; 32 Suppl 4():S29-35. PubMed ID: 18719595
    [Abstract] [Full Text] [Related]

  • 22. Anti-anginal effects of partial fatty acid oxidation inhibitors.
    Lam A, Lopaschuk GD.
    Curr Opin Pharmacol; 2007 Apr; 7(2):179-85. PubMed ID: 17307396
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The malonyl CoA axis as a potential target for treating ischaemic heart disease.
    Ussher JR, Lopaschuk GD.
    Cardiovasc Res; 2008 Jul 15; 79(2):259-68. PubMed ID: 18499682
    [Abstract] [Full Text] [Related]

  • 25. Comparative energy metabolism in cultured heart muscle and HeLa cells.
    Stanisz J, Wice BM, Kennell DE.
    J Cell Physiol; 1983 Jun 15; 115(3):320-30. PubMed ID: 6853608
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Carbohydrate-enriched diet impairs cardiac performance by decreasing the utilization of fatty acid and glucose.
    Pôrto LC, Savergnini SS, de Castro CH, Mario EG, Ferreira AV, Santos SH, Andrade SP, Santos RA, de Almeida AP, Botion LM.
    Ther Adv Cardiovasc Dis; 2011 Feb 15; 5(1):11-22. PubMed ID: 21282201
    [Abstract] [Full Text] [Related]

  • 28. [Changes of myocardial enzymes related to glycolysis and fatty acid metabolism in chronic myocardial ischemia: experiment with pigs].
    Gong J, Wang HY, Pu JL, Zheng YL, Shen R, Yang MF, He ZX.
    Zhonghua Yi Xue Za Zhi; 2008 Aug 12; 88(31):2209-13. PubMed ID: 19080674
    [Abstract] [Full Text] [Related]

  • 29. Metabolic therapy in the treatment of ischaemic heart disease: the pharmacology of trimetazidine.
    Stanley WC, Marzilli M.
    Fundam Clin Pharmacol; 2003 Apr 12; 17(2):133-45. PubMed ID: 12667223
    [Abstract] [Full Text] [Related]

  • 30. Trimetazidine-induced enhancement of myocardial glucose utilization in normal and ischemic myocardial tissue: an evaluation by positron emission tomography.
    Mody FV, Singh BN, Mohiuddin IH, Coyle KB, Buxton DB, Hansen HW, Sumida R, Schelbert HR.
    Am J Cardiol; 1998 Sep 03; 82(5A):42K-49K. PubMed ID: 9737485
    [Abstract] [Full Text] [Related]

  • 31. Fatty acid translocase/CD36 deficiency does not energetically or functionally compromise hearts before or after ischemia.
    Kuang M, Febbraio M, Wagg C, Lopaschuk GD, Dyck JR.
    Circulation; 2004 Mar 30; 109(12):1550-7. PubMed ID: 15023869
    [Abstract] [Full Text] [Related]

  • 32. Metabolic and endothelial effects of trimetazidine on forearm skeletal muscle in patients with type 2 diabetes and ischemic cardiomyopathy.
    Monti LD, Setola E, Fragasso G, Camisasca RP, Lucotti P, Galluccio E, Origgi A, Margonato A, Piatti P.
    Am J Physiol Endocrinol Metab; 2006 Jan 30; 290(1):E54-E59. PubMed ID: 16174656
    [Abstract] [Full Text] [Related]

  • 33. [Myocardial metabolism abnormalities during ischemia and reperfusion].
    Argaud L, Ovize M.
    Arch Mal Coeur Vaiss; 2000 Jan 30; 93(1):87-90. PubMed ID: 11227723
    [Abstract] [Full Text] [Related]

  • 34. [Metabolic therapy for heart failure].
    Loiacono F, Alberti L, Lauretta L, Puccetti P, Silipigni C, Margonato A, Fragasso G.
    Recenti Prog Med; 2014 Jan 30; 105(7-8):288-94. PubMed ID: 25072544
    [Abstract] [Full Text] [Related]

  • 35. [Ischemic heart disease and left ventricular dysfunction: the role of trimetazidine].
    Belardinelli R.
    Ital Heart J; 2004 Mar 30; 5 Suppl 2():23S-28S. PubMed ID: 15074774
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Fatty acid oxidation inhibitors in the management of chronic complications of atherosclerosis.
    Folmes CD, Clanachan AS, Lopaschuk GD.
    Curr Atheroscler Rep; 2005 Feb 30; 7(1):63-70. PubMed ID: 15683605
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of free fatty acids metabolism as a therapeutic target in patients with heart failure.
    Fragasso G.
    Int J Clin Pract; 2007 Apr 30; 61(4):603-10. PubMed ID: 17394434
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.